Furthermore, we investigated the effect of rabeprazole on lipid droplet accumulation and tumor growth after ARF1 knockdown to prove that the anti-tumor effect of rabeprazole is ARF1 dependent. This evidence concerns the gene ARF1 and neoplasm.